Tag Archives: liver disease

August, 2018

9 August
Ambys Medicines and Takeda Partner to Develop First-in-Class Therapies for Serious Liver Diseases

REDWOOD CITY, Calif. & OSAKA, Japan–(BUSINESS WIRE)–Ambys Medicines, a biotechnology company focused on the discovery and development of transformative therapies for people with serious liver disease, and Takeda Pharmaceutical Company Limited [TSE:4502] (“Takeda”) announced today that they have entered into a partnership to support the advancement of the Ambys platform …
Share

12 April
Alexion to Acquire Wilson Therapeutics and its Rare Liver Disorder Drug

NEW HAVEN, Conn.–(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Wilson Therapeutics AB (publ) announced today that Alexion has made a recommended public cash offer to the shareholders in Wilson Therapeutics to acquire all outstanding shares in Wilson Therapeutics by way of a tender offer, through a wholly-owned subsidiary. Wilson Therapeutics is …
Share

11 November
FDA Approves Gilead’s Vemlidy for Treatment of Hepatitis B

FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Vemlidy® (tenofovir alafenamide, TAF) 25mg, a once-daily treatment for adults with chronic hepatitis B virus (HBV) infection with compensated liver disease. Vemlidy has a boxed warning in its product label …
Share

26 March
Amgen’s deCODE Genetics Study Reveals Clues to Disease-Causing Genes

Amgen’s deCODE Genetics published four landmark papers built on whole-genome sequence data from more than 100,000 people from across Iceland. Research groups led by scientists from Amgen’s deCODE Genetics reported data that comprise the largest set of human genome sequenced from a single population in Nature Genetics. Four separate papers …
Share